HOW AND WHERE TO BUY DYAZIDE (TRIAMTERENE, HYDROCHLOROTHIAZIDE) 50 MG / 25 MG TABLETS OR CAPSULES ONLINE:
from $0.95 per pill
10% discount coupon: hf-5478
DRUGS FOR HEALTH
from $1.01 per pill
5% discount coupon: A1XKPKC
from $1.24 per pill
5% discount coupon: dmeds5
DYAZIDE (TRIAMTERENE, HYDROCHLOROTHIAZIDE) CAPSULES: USE IN SPECIFIC POPULATION
Pregnancy Category C
Animal reproduction studies to determine the potential for fetal harm by Dyazide have not been conducted. However, a One Generation Study in the rat approximated composition of Dyazide by using a 1:1 ratio of triamterene to hydrochlorothiazide (30:30 mg/kg/day); there was no evidence of teratogenicity at those doses which were, on a body-weight basis, 15 and 30 times, respectively, the MRHD, and on the basis of body-surface area, 3.1 and 6.2 times, respectively, the MRHD.
The safe use of Dyazide in pregnancy has not been established since there are no adequate and well-controlled studies with Dyazide (Triamterene with Hydrochlorothiazide) capsules in pregnant women. This medication should be used during pregnancy only if the potential benefit justifies the risk to the fetus.
Reproduction studies have been performed in rats at doses as high as 20 times the MRHD on the basis of body-weight, and 6 times the human dose on the basis of body-surface area without evidence of harm to the fetus due to triamterene.
Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
Hydrochlorothiazide was orally administered to pregnant mice and rats during respective periods of major organogenesis at doses up to 3,000 and 1,000 mg/kg/day, respectively. At these doses, which are multiples of the MRHD equal to 3,000 for mice and 1,000 for rats, based on body-weight, and equal to 282 for mice and 206 for rats, based on body-surface area, there was no evidence of harm to the fetus.
There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.
Thiazides and triamterene have been shown to cross the placental barrier and appear in cord blood. The use of thiazides and triamterene in pregnant women requires that the anticipated benefit be weighed against possible hazards to the fetus. These hazards include fetal or neonatal jaundice, pancreatitis, thrombocytopenia, and possible other adverse reactions which have occurred in the adult.
Thiazides and triamterene in combination have not been studied in nursing mothers. Triamterene appears in animal milk; this may occur in humans. Thiazides are excreted in human breast milk. If use of the combination drug product is deemed essential, the patient should stop nursing.
Safety and effectiveness of Dyazide (Triamterene with HCTZ) in pediatric patients have not been established.
Buy Dyazide (Triamterene/HCTZ) Online
Dyazide prescribing information
Copyright © 2016-2019 Triamterene-Hydrochlorothiazide.cheapmeddrugs.org, a division of Pharma-Doctor.com pharmaceutical network.
Home Page |
Cookies Policy |
Terms of Service |